Sec Form 13G Filing - Gemini Israel V Limited Partnership @ WalkMe Ltd.

Sec Form 13G Filing - Gemini Israel V Limited Partnership filing for WalkMe Ltd. (WKME) - 2024-02-13

Insider filing report for Changes in Beneficial Ownership

Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Link

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1

(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2

(Amendment No. 2)*

WalkMe Ltd.

(Name of Issuer)

Ordinary Shares, no par value

(Title of Class of Securities)

M97628107

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP NO. M97628107		13 G		Page 2 of 12 Pages

(1)

This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to beneficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Gemini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)	Based on 87,861,147 of the Issuer’s ordinary shares outstanding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 3 of 12 Pages

(1)

(2)	Based on 87,861,147 of the Issuer’s ordinary shares outstanding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 4 of 12 Pages

(1)

(2)	Based on 87,861,147 of the Issuer’s ordinary shares outstanding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 5 of 12 Pages

(1)

This Schedule 13G is filed on behalf of Gemini Israel V Limited Partnership (“Gemini V”), Gemini Capital Associates V LP (“Gemini Associates LP”), Gemini Capital Associates V GP, Ltd. (“Gemini Associates GP”), Gemini Partners Investors V L.P. (“Gemini Partners”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP, which is the general partner of Gemini V, and each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the ordinary shares of the issuer held by Gemini V. Gemini Israel is the general partner of Gemini Partners and may be deemed to beneficially own the ordinary shares of the issuer held by Gemini Partners. Ezra and Sela are the managing partners of Gemini Associates GP and Gemini Israel, and each of Ezra and Sela may therefore be deemed to ben eficially own the ordinary shares of the issuer held by Gemini V and Gemini Partners. Each of Gemini Associates GP, Gemini Associates LP, Gemini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares of the issuer held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein. The Reporting Persons may be deed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)	Based on 87,861,147 of the Issuer’s ordinary shares outstanding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 6 of 12 Pages

(1)

(2)	Based on 87,861,147 of the Issuer’s ordinary shares outsta nding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 7 of 12 Pages

(1)

(2)	The reported ordinary shares of the Issuer represent 42,157 shares held directly by Menashe Ezra; 20,628 of such shares are options available for exercise and 10,227 of such shares are restricted stock units.

(3)	Based on 87,861,147 of the Issuer’s ordinary shares outstanding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 8 of 12 Pages

(1)

(2)	Based on 87,861,147 of the Issuer’s ordinary shares outstanding as of February 28, 2023, as reported in the Issuer’s Annual Report on Form 20-F for the annual period ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023.


CUSIP NO. M97628107		13 G		Page 9 of 12 Pages

Item 1(a)

Name of Issuer:

WalkMe Ltd.

Item 1(b)

Address of Issuer’s principal executive offices:

1 Walter Moses Street

Tel Aviv, 6789903, Israel

Items 2(a)

Name of Reporting Persons filing:

Each of the following is a reporting person (“Reporting Person”):

Gemini Israel V Limited Partnership

Gemini Capital Associates V L.P.

Gemini Capital Associates V GP Ltd.

Gemini Partners Investors V L.P.

Gemini Israel Funds IV Ltd.

Menashe Ezra

Yossi Sela

Item 2(b)

Address or principal business office or, if none, residence:

The principal business address of each Reporting Person is:

c/o Gemini Israel Ventures

1 Shankar St , WeWork, 1st Floor

Herzliya, Israel

Item 2(c)

Citizenship:

Reference is made to the response to item 4 on each of pages 2-8 of this Schedule 13G (this “Schedule”), which responses are incorporated herein by reference.

Item 2(d)

Title of class of securities:

Ordinary Shares

Item 2(e)

CUSIP No.:

M97628107

Item 3

If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a:

Not applicable.

Item 4

Ownership

Reference is hereby made to the responses to items 5-9 and 11 of pages 2—8 of this Schedule, which responses are incorporated by reference herein.


CUSIP NO. M97628107		13 G		Page 10 of 12 Pages

Gemini Capital Associates V LP (Gemini Associates LP) is the general partner of Gemini Israel V Limited Partnership (Gemini V) and Gemini Capital Associates V GP, Ltd. (Gemini Associates GP) is the general partner of Gemini Associates LP. Gemini Israel Funds IV Ltd. (Gemini Israel) is the general partner of Gemini Partners Investors V L.P. (Gemini Partners). Menashe Ezra and Yossi Sela are the managing partners of Gemini Associates GP and Gemini Israel. Each of Gemini Associates LP, Gemini Associates GP, Gemini Israel, Ezra and Sela hereby disclaims beneficial ownership of the ordinary shares held by Gemini V and Gemini Partners except to the extent of its or his pecuniary interest therein.

Item 5

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☐

Item 6

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not applicable.

Item 8

Identification and Classification of Members of the Group

Not applicable.

Item 9

Notice of Dissolution of Group

Not applicable.

Item 10

Certifications

Not applicable.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2024



GEMINI ISRAEL V LIMITED PARTNERSHIP

By: GEMINI CAPITAL ASSOCIATES V GP LTD.

Its: General Partner

By:	/s/ Yossi Sela	By:	/s/ Menashe Ezra
Name:	Yossi Sela	Name:	Menashe Ezra
Title:	Managing Partner	Title:	Managing Partner

GEMINI CAPITAL ASSOCIATES V L.P.

By: GEMINI CAPITAL ASSOCIATES V GP LTD.

Its: General Partner

By:	/s/ Yossi Sela	By:	/s/ Menashe Ezra
Name:	Yossi Sela	Name:	Menashe Ezra
Title:	Managing Partner	Title:	Managing Partner

GEMINI CAPITAL ASSOCIATES V GP LTD.

By:	/s/ Yossi Sela	By:	/s/ Menashe Ezra
Name:	Yossi Sela	Name:	Menashe Ezra
Title:	Managing Partner	Title:	Managing Partner

GEMINI PARTNERS INVESTORS V L.P.

By: GEMINI ISRAEL FUNDS IV, LTD.

Its: General Partner

By:	/s/ Yossi Sela	By:	/s/ Menashe Ezra
Name:	Yossi Sela	Name:	Menashe Ezra
Title:	Managing Partner	Title:	Managing Partner


GEMINI ISRAEL FUNDS IV LTD.

By:	/s/ Yossi Sela	By:	/s/ Menashe Ezra
Name:	Yossi Sela	Name:	Menashe Ezra
Title:	Managing Partner	Title:	Managing Partner

/s/ Menashe Ezra

Menashe Ezra

/s/ Yossi Sela

Yossi Sela

NAMES OF REPORTING PERSONS

Gemini Israel V Limited Partnership

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

00-0000000

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) ☐ (b) ☒ (1)

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Israel